FINWIRES · TerminalLIVE
FINWIRES

SHA:688617

4 stories mentioning SHA:688617Updated 28d ago

Every FINWIRES story that references SHA:688617, newest first.

Asia

APT Medical to Waive Preemptive Rights on Related Party Transaction; Shares Up 4%

APT Medical (SHA:688617) plans to waive its preemptive rights in the transaction where Vice Chair Cheng Zhenghui will acquire 25% of controlling subsidiary Haoying Medical for 112.5 million yuan.Post-transaction, the medical device maker will retain 63.48% ownership and control of Haoying Medical, according to a Thursday filing with the Shanghai bourse.Cheng holds a 16.68% stake in APT Medical.Shares of the company rose 4% in recent trade.

SHA:688617
Research

Huachuang Securities Starts APT Medical at Add with 253 Yuan Price Target

APT Medical (SHA:688617) has an average rating of buy and mean price target of 335.39 yuan, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

SHA:688617
Asia

APT Medical Chair to Buy Up to 3 Million Yuan in Shares; Shares Up 3%

APT Medical (SHA:688617) said Chair Zhao Yuxiang plans to purchase between 2 million yuan and 3 million yuan worth of company shares between May 11 and May 31.Zhao currently holds no shares, according to a Tuesday filing with the Shanghai bourse.Shares of the medical device maker rose 3% in recent trade.

SHA:688617
Asia

APT Medical Names Chairman

APT Medical (SHA:688617) appointed Zhao Yuxiang chairman, according to a Shanghai bourse filing on Friday.Zhao will take over from Ge Hao, who resigned due to changes in work arrangements but will continue to serve as a director of the Chinese medical device maker.

SHA:688617

Track with the FINWIRES app suite